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A New Tool for 
Supporting Innovation in 
Biotech Co-Innovation 
and the Role of 
Economic Developers
ABSTRACT
Biotech companies have been perceived has the Saint-Graal for economic devel-
opment since a few years. But the economic downturn and a misunderstanding of 
the shift in innovation process, from a stage gate process to a user driven process 
placed, impairs biotech companies. Economic developer, which aims is to foster 
innovation to induce economic development asked themselves how to help innova-
tion in the biotech sector to reach the market more rapidly and more eﬃciently. This 
book chapter present an overview in the innovation shift from the supply side to the 
demand side and propose a new model of intervention for economic developers in 
this new context of co-innovation.
Marina Frangioni
Bishop’s University, Canada
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INTRODUCTION
Since the last 50 years, innovation has been perceived as a stage gate process 
involving university and manufacturers. A lot of effort has been made to support 
technology transfer from research centers to companies to market. In the meantime, 
Porter (1998) has developed his now renowned concept of clusters. Cities all around 
the world have put in place innovation strategies consistent with the geographic 
concentration of firms in selected industrial sectors. Montreal was no exception and 
the biotech cluster was one of the first, which has been brought to life back in the 
00. InVivo (the cluster’s Administration) is now at the crossroads and tries to help 
manufacturers and entrepreneurs to build a new pipeline of products and energize a 
new round of development. In history then, most of public policies and support was 
designed to help manufacturer in capturing innovation coming from research lab. 
But, many sociologists have stressed the importance of the network and the social 
fabric and users for the diffusion and the acceptance of innovation through society.
Despite this researches at the academic level, few works has been done to inte-
grated, in one hand this new source of innovation (users) in the toolbox of economic 
developers and, in the other hand to understand and structure the demand side to 
foster innovation.
BACKGROUND
Main Focus of the Chapter
The aim of this paper is to see how the rules have changed for economic developers 
and how a new model can be proposed to help them to enrich their action towards 
entrepreneurs and business community. Moreover, this paper will study in the biotech 
sector how this proposed model could be implement.
Innovation Evolution: A Quick Overview
Innovation is recognized as the engine of economic and society development. In 
the early work of economists, it was identified mostly as technological progress. 
The seminal work of Schumpeter, demonstrated the importance of economic actor 
such as innovator (manufacturer and entrepreneur) in the technological progress 
and its way to transform society (destructive creation). Bust mostly of these works 
are based on a linear view of innovation.
In recent years, new perspectives on innovation are emerging. This is called 
«the demand side of innovation». It is based on the idea that users and communities 
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can be more then helpful in nurturing innovation process. The work of Von Hippel 
(1986, 2005) on lead users intervenes in the definition of the demand side innova-
tion process, as well as work on network (Lemieux, 1976; Granovetter, 1978; Burt 
& Celotto, 1992; Cohendet, Roberts & Simon, 2010; Lemieux & Ouimet, 2006).
Most of authors or practitioners tend to oppose those two perspectives. But it 
must be sees as the two sides of the same coin. In that perspective Figure 1 tends 
to give a quick overview of the two side of innovation process.
The first one, called the A perspective is mostly based on a linear view on in-
novation. In this perspective, the focus is clearly on the firm as the engine for 
economic growth and development. 
Since 30 years, innovation has been perceived as a stage gate process involving 
universities and manufacturers. The main idea is to accelerate the commercialization 
between the bench and the market. 
In this attempt to support innovation process and due out commercialization, 
strategies are deeply rooted in a linear vision of innovation (Von Hippel, 2005). The 
supply side of innovation, coming from labs and manufacturers, are at the core of 
innovation strategies, in order to increase the number of patents, commercialization 
and competitive advantage. 
Thus, a lot of effort has been made to support technology transfer from research 
centers to companies and to market. In Quebec, with those kinds of strategies in 
mind, Valorisation Recherche Québec was created in the 90’ and has funded several 
Figure 1. Two perspectives on innovation
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companies in order to support and accelerate tech transfer from universities to firm 
through valorization companies. Today, some of those companies, issued from VRQ, 
still exist but their business model needs to be re-invented.
Also, in this perspective, geographical proximity then becomes instrumental to 
accelerate this transfer. Territorial policies have been developed to help clusteriza-
tion and tech transfer. In Montreal, scientific and technological parks have been 
developed such as Technoparc Montreal or Technopole Angus.
Nowadays, in what it is called the B perspective, no one can doubt that science 
and technologies are more and more complex. As a result, knowledge is also more 
distributed which means that people need wider networks to embrace specificities 
of their domain. Networks also become more heterogeneous and contributors are 
multiple. Thus, networks perspectives appear, bringing practitioners to include 
ecosystemic option in their strategies. Figure 2 offers a synthetic overview of this 
complexification process.
Von Hippel (1986, 2005) was one of the first to highlight the demand side of 
innovation, where some users can be very contributive to innovation process. Lead-
users are defined by Von Hippel as «users that are engaged in developing or modi-
fying products». They are actually 10 to 40 percent of users. Moreover, several 
studies have shown that many of the innovations made by lead users are «judged to 
be commercially attractive or have actually been commercialized by manufacturers». 
With lead users as contributors to the innovation process come to wider the networks 
involved in this process. So, it is important to understand how those networks struc-
tured to support hi-tech sectors such as biotechs.
Figure 2. Innovation: A complex process
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With the works of Cooke (2007a, 2007b) on Regional Innovation System (RIS), 
there is classification on the structure of the network. How its governance is struc-
ture and the source of innovation. It has been demonstrated that initial conditions 
and path dependency are important in the development of RIS and then of regional 
innovation. In other words, innovation paths are clearly determined by social and 
territorial construction: the structure of the network.
Because tools for innovation support on the demand side are not so well defined, 
innovation support emphasized strategies in a supplier view. For example, in the 
life science sectors, it aims to put right conditions in place to help entrepreneurs to 
have competitive advantage. 
Quebec had developed a strategy regarding patents in the pharmaceutics sector 
and their duration. But, in the 00’, the biotech revolutions echoed to be a solution 
for pharmaceuticals to reload the potential research on new cure. 
In economic development and entrepreneurial support, the ecosytemic premises 
of innovation appeared with the work of Porter (1998, 2001). At the beginning Porter 
worked at the national level, then adapted his diamond shape model to the regional 
level (Porter 1998, 2001). The era of clusters as a management and decision tool 
came into place. Cities, all around the world have put in place innovation strategies 
consistent with the geographic concentration of firms in selected industrial sectors. 
Whereas, Marshall-Arrow-Romer (MAR) industrial districts brought innovation 
with a concentration of industries in the same field and end-up with monopolistic 
equilibrium, in the Porter’s clusters, innovation occurs because of a simulation 
process engaged under the rules of competition. In the Porter vision, innovation 
began to be a complex process where suppliers, customers, and related industries 
work hand in hand to reach a dominant position on the market. 
Montreal was no exception and the biotech cluster was one of the first, which 
has been brought to life back in the 00’. InVivo (the cluster secretary) is now at the 
crossroad and tries to help manufacturers and entrepreneurs to build a new pipeline 
of products and energize a new round of development. The idea is to enhance busi-
ness model from a chemistry model to a biotech model, based only on the market 
offer to a model, which also support the demand side (users). Until now, it should be 
underline the quite good performance of the InVivo cluster. But since a few years, 
the industry, as well as the InVivo needs to redefine their model. 
This need come from the changing business model in pharmaceutical industry, 
which implies a will of a change in the way biotech clusters support their members, 
but also from different initiatives on the demand side of innovation which is promis-
ing for supporting innovation even in the biotechs sector.
The reality is that innovation process and entrepreneurship support are two-fold. 
First, it depends on the supply side of entrepreneurs (intellectual property, funding, 
counselling, etc.) and on the demand side, which include users. In history then, 
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most of public policies and support was designed to help manufacturer in captur-
ing innovation coming from research lab. But, many sociologists have stressed the 
importance of the network and the social fabric for the diffusion and the acceptance 
of innovation through society.
In regards of the Von Hippel’ (1986) seminal work a new source of innova-
tion has been pinpointed: the users. Chesbrough shown that the management of 
intellectual properties tend also to change. His now well-known open innovation 
concept brought the idea to a proactive intellectual property (IP) management. The 
way companies can benefit of research from others firms (even competitive ones) 
or how they can capitalize on their own research or IP. Subsequently, open innova-
tion is about bringing idea into the company coming from anywhere. It is about 
collective intelligence and the way it could help entrepreneurs to boost their own 
innovation process. 
Most recently, some different strategies, based on the demand side of innovation, 
are developed as per NEOMED project in Montréal. The NEOMED Institute «is a 
response to the changing pharmaceutic’s R&D business model. 
In view of the considerable gap between basic research and the commercializa-
tion of new drugs, we seek to create a bridge. It offers several facilities based on 
collaboration, creativity and innovation. 
But, in the perspective of the demand side of innovation, this article explores a 
way to put the exercise of the NEOMED project-like a step further. It proposes a 
way to include users and new forms of entrepreneurship (Frangioni, 2015) in the 
support of innovation using these enriched communities as the engine of innova-
tion. In fact, despite researches at the academic level, few works have been done 
to integrated, in one hand this new source of innovation (users) in the toolbox of 
economic developers, especially in the biotechs sector and, in the other hand to 
understand and structure the demand side to foster innovation.
Highlight 1: The Fold-It Experiment
Created by various departments and labs from the University of Washington, Fold-it 
explores the process by which living beings create the primary structure of proteins. 
The protein biosynthesis is reasonably well understood, as is the means by which 
proteins are encoded as DNA. Determining how the primary structure of a protein 
turns into a functioning three-dimensional structure – how the molecule “folds” – 
is more difficult; the general process is known, but predicting protein structures is 
computationally demanding - gameforchange.org (2015).
The serious game Fold-it was created to accelerate research on proteomics and 
therefore research on human health. In three weeks, with the collective intelligence 
of the players, Fold-it has determined the three-dimensional shape of the protease 
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that was involved in the spread of the AIDS virus in monkeys. Feat that had not 
been done after 10 years of research in scientific laboratories. Contributors to the 
game are both researchers in biology, medicine, but also designers, students, etc. 
Obviously, this development allows now developing experimental therapeutic in 
struggle against the AIDS virus in humans.
A NEW ROLE FOR ECONOMIC DEVELOPER: CO-INNOVATION
One question is still wide open, how economic developer could help to foster in-
novation, regarding the demand side of innovation process? The objective is not to 
wipe out the tools on the supply side of innovation, but to add new way of support-
ing innovation including users. In fact, we can sum-up the two side of innovation 
as two different, but complementary perspectives.
With a research on economic developers needs and tools in Quebec and France, 
the author has developed an intervention model for economic developers who want 
to integrate in their practice the co-innovation principle. The model is not a general 
model, but instead a model at the meso-economic level, which aim is to foster co-
innovation as a tool, which complement existing one.
Stars represent specific actions of economic developer (ED). From each relevant 
ecosystem, ED connects to several individuals from each of these ecosystems, which 
is the agent network. It should be noted that according to the theory of structural 
holes (Burt and Celotto, 1992), the agent must connect to networks that have few 
connections together.
Then, he can have a deeper and broader vision of the problems or needs that 
emerge in a given area. Moreover, the principles of co-innovation are to allow for 
diversity (of individuals, communities and sectors) in a form of proximity (both 
geographical, but also cognitive, social, organizational and institutional). The notion 
of in-between centrality is also important because the ED plays an intermediary 
role in the developed model.
With business intelligence, the agent identifies some related elements through 
its network (and thus relays with different ecosystems). He developed more links 
with some required network members to get a better understanding of these related 
elements. This step is a work of agitation and disturbance that runs the network and 
which can be problematic and needs. 
The phase of agitation and disturbance is important where ED must identify 
problematic or sufficiently complex needs so they can create sufficient working 
voltage that leads to action. Furthermore, the different points of view, here diversity 
in proximity, accelerate and intensify the work of agitation and disturbance of the 
agent. At that stage, meaning for the community begins to appear and the agent 
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will work to integrate the concept of user to complete the perspective of technical 
experts, by the secular experts. 
These issues and needs remain diffuse at this stage, and ED must conduct an 
intermediary step and innomediation. Here, he acts as an interface to structure the 
needs and problems, on one hand, and bring the best players in the ecosystem, on 
the other hand, based on sometimes divergent interests, which can work to the iden-
tification of a common solution. Here, the ED agent must begin formatting content 
for defining experimental axes and methodologies that will be involved.
Working with this structure, the agent is able to create intrapreneurial opportuni-
ties. These opportunities are those, which may lead to structuring projects carried by 
communities. In this context, the intrapreneurial characteristics of the agent are put 
to use: he must have a vision, build alliances and structure projects and be tenacious 
as the co-innovation projects are still unclear, the agent often encounters difficulties 
in his own organization, which is not necessarily familiar with the principles and 
methods of co-innovation.
In fact, at this stage the agent begins to offer and sell his project within its own 
organization (intrapreneur) as well as in the community (exopreneur). He must 
show determination, because he finds himself in competition with projects of his 
colleagues in a world where resources are scarce (public funding).
In the next step, the agent builds a community of interest in which he is also one 
of the stakeholders. The thus created community defines strategic projects that will 
allow the implementation of innovative solutions to the needs and issues identified 
beforehand. Structuring projects are intended to help structure new emerging areas 
of development, but with great potential. This requires the creation of co-creatives 
platforms and third-places that can be digital (crowdsourcing, for example) or 
attendance-based (learning circles, for example) or a combination of both (Living 
Labs, for example).
It is important here to note that the concept of third-place or platform is critical 
to the success of collaborative or co-creatives projects. Indeed, communities need 
to express themselves in a space that is facilitating and not identified to any specific 
stakeholder. Although these platforms and third places can be physical places, they 
can be virtual as long as collaboration and co-creation can be expressed. Thus, 
according to Simon (2014), it takes the concept of physical locations (places) and 
semantic spaces (spaces) in which co-innovation can be expressed.
Note that this part of the process is represented in Figure 3 by circles, in order to 
show the dynamic mechanism. The constitution of solutions in innovative projects 
can itself create a feedback loop that leads to the identification of new needs and new 
issues, creating an additional iterative loop. However, the concept of animation is 
essential for innovative solutions to emerge and maintain the interest of participants 
in the community throughout the process. The animation is done through collabora-
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tive and co-creative tools. The choice depends on the state and the objectives of the 
emerging projects.
The animation requires an in depth knowledge of the sector and members of the 
communities from the facilitator. Financial people often see this task as ancillary 
in platform or to third place, while it is at the heart of the success of this kind of 
strategy.
The identification of innovative solutions creates entrepreneurial opportunities 
that can be seized by entrepreneurs. Entrepreneurial opportunities can come from 
structuring projects in which they participate directly or indirectly over the business 
Figure 3. Intervention model for economic developers in a co-innovation context
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serendipity that is created in co-creative platforms and third-places. Furthermore, 
the development of entrepreneurial opportunities is built around a real market with 
real users that can serve as core to developing a community of users and customers, 
which can also improve along the way. Moreover, the use of tools and methodolo-
gies, and methods of co- innovation processes and results in negotiated rather than 
consensual solutions. The difference between negotiated and consensual lays here 
in the fact that in the first, stakeholders build their product or service by adding 
concepts related to common needs, in the second, the notion of consensuality takes 
a subtraction character. Indeed, for the consensual solution forms, one has to drop 
items that seem less important during the process. 
Finally, the community comes to the end of a product or service that is found 
to be the lowest common denominator. In other words, the product or service does 
not really please anyone, but it does not displease to anyone also. In contrast, in 
the negotiated approach, the development of the product or service is done on an 
incremental basis. Thus, people constantly add to the initial idea, to reach the highest 
common denominator in some way. Moreover, when these spaces are real physical 
spaces as creative hubs, co-working spaces such gains are increasingly important 
as the pooling of business solutions is growing.
Ultimately, the role of the ED is twofold. It is targeted through certain actions 
that should be implemented, firstly to define needs or problems, to bring together 
communities that will structure projects and, secondly, to have a continuous action 
in relationships with his various networks. Although ED is a network agent, the 
fundamental difference that can be noted compared to more traditional methods 
lies in the locus of governance and participation, according to the principles of col-
laboration and co-creation. Moreover, when these spaces are real physical spaces 
as creative hubs, co-working spaces and such gains are increasingly important as 
the pooling of business solutions is growing.
As the complexity of knowledge is increasing, the ED needs to take more and 
more collaborative and co-creative posture and in the meantime learns the adoption 
of collaborative and co-creative tools for which he is ill informed or ill-equipped. 
The intervention model is a response to this lack of knowledge.
Some other elements are also to be considered, such as the stage of development of 
innovative solutions. At the pre-competitive stage, for example, a more open culture 
(especially with recent examples in biotechnology, traditionally closed culture and 
based on the management of intellectual property) can be integrated even in sectors 
that tend to close. However, in competitive phases, which are the formalization of 
a marketable product, there is a more closed approach.
The ED should also have a good read of the industry in which it wishes to 
intervene and when the procedure is done. In the case where innovative solutions 
are not mature, one must wonder about the fact whether the uses are known or not. 
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In cases where technologies are not mature and uses are unknown, the co-creative 
technics should be promoted in order to reveal and determined the type of innova-
tive solutions to be developed. This could be done by the use of realistic scenario 
in which users are deeply involved.
This can be illustrated by the example of the Living Lab SAT / Sainte-Justine 
where innovative solutions are relatively mature (3D immersive spaces, creating 
therapeutic avatars for children with serious illnesses - cancer - or disabilities - 
autism – by example), but the uses are little known: how to improve therapeutic 
techniques using 3D environments? How customers (children, parents, caregivers, 
etc.) can target use appropriate these new treatment spaces? Otherwise, if innova-
tive solutions are mature and known uses, then the ED officer should opt for more 
traditional support for entrepreneurship: advice, support for financing, real estate, 
if any. But, it may guide communities towards some elements of collaboration and 
co-creation. 
In the case of biotech sector, some technologies are more mature whereas some 
other needs to gain in maturity. In the meantime, uses are sometimes well defined, 
whereas some need also to be refined. This is why I insist, particularly in this sec-
tor, in the complementary use of the perspective A and B in the support of innova-
tion by ED agent. The key is not to replace traditional methods by collaborative 
and co-creative methods but more precisely define how and when use either of the 
methods properly. 
FUTURE RESEARCH DIRECTIONS
The tools of co-innovation support compliant with the new intervention model 
developed in this book chapter should be fully developed for the biotech sector. 
An action research should be put in place to better understand the specificities of 
the sector to implement a strategy build around co-innovation in regards of the 
specific problematic of this sector. The model developed here should be also tested 
and improved.
CONCLUSION
This paper aims to define a model in order to complement the existing tools for ED 
agent in order to support innovation and entrepreneurship. It underlines the impor-
tance of the «demand side» in the innovation process. The co-innovation tools as 
platform or third-place is are instrumental to foster new source of innovation. 
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Of course, this model should be applied differently regarding the particularity of 
different sectors. The ED should have an in-depth knowledge of the sector, but also 
be connected to different ecosystem in order to develop heterogeneous communities 
and help the to support entrepreneurship in the biotech sector. One of the key element 
to understand in the biotech sector, is the degree of maturity of the technologies. 
Use of traditional method to support innovation should be put in perspective with 
the degree of maturity of the technologies and the knowledge on uses.
More research should be done to improve the model and a toolbox (guidelines 
of co-innovation tools) for ED is currently under development.
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